PCSK9inhibitorsdrug classofalirocumabdiet with lessthan 7% ofsaturatedfatsnonpharmASCVDtherapyHDL"good"cholesterolfoamcellamacrophagethat hasengulfed ox-LDLphysicalactivitynonpharmASCVDtherapyfattystreakname ofstructure thatforms froman aggregateof foam cellsCADclinicalimplication ofatherosclerosissynthesis ofcholesterolwithin thebodyendogenouscholesterolmetabolismezetimibedrug thatinhibitscholesterolabsorption inthe smallintestinereducedblood supplyto the armsand/or legsPeripheralarterydisease(PAD)activatesPPAR-αto ↓ LDLand ↓ TGfibratesMOAtransportcholesterolto peripheraltissuesfunction ofchylomicronsinhibitsHMG-CoAreductasestatinsMOA150desiredTG levelsare under___ mg/dLLDL"badcholesterol"supplementationof cholesterolfrom dietexogenouscholesterolmetabolism55women over__ yearshave ahigherASCVD risk45men over __years havea higherASCVD riskbile acidsequestrantsdrugclass ofcolestipol200desired totalcholesterollevels areunder ___mg/dLPCSK9inhibitorsdrug classofalirocumabdiet with lessthan 7% ofsaturatedfatsnonpharmASCVDtherapyHDL"good"cholesterolfoamcellamacrophagethat hasengulfed ox-LDLphysicalactivitynonpharmASCVDtherapyfattystreakname ofstructure thatforms froman aggregateof foam cellsCADclinicalimplication ofatherosclerosissynthesis ofcholesterolwithin thebodyendogenouscholesterolmetabolismezetimibedrug thatinhibitscholesterolabsorption inthe smallintestinereducedblood supplyto the armsand/or legsPeripheralarterydisease(PAD)activatesPPAR-αto ↓ LDLand ↓ TGfibratesMOAtransportcholesterolto peripheraltissuesfunction ofchylomicronsinhibitsHMG-CoAreductasestatinsMOA150desiredTG levelsare under___ mg/dLLDL"badcholesterol"supplementationof cholesterolfrom dietexogenouscholesterolmetabolism55women over__ yearshave ahigherASCVD risk45men over __years havea higherASCVD riskbile acidsequestrantsdrugclass ofcolestipol200desired totalcholesterollevels areunder ___mg/dL

ASCVD Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
  1. drug class of alirocumab
    PCSK9 inhibitors
  2. nonpharm ASCVD therapy
    diet with less than 7% of saturated fats
  3. "good" cholesterol
    HDL
  4. a macrophage that has engulfed ox-LDL
    foam cell
  5. nonpharm ASCVD therapy
    physical activity
  6. name of structure that forms from an aggregate of foam cells
    fatty streak
  7. clinical implication of atherosclerosis
    CAD
  8. endogenous cholesterol metabolism
    synthesis of cholesterol within the body
  9. drug that inhibits cholesterol absorption in the small intestine
    ezetimibe
  10. Peripheral artery disease (PAD)
    reduced blood supply to the arms and/or legs
  11. fibrates MOA
    activates PPAR-α to ↓ LDL and ↓ TG
  12. function of chylomicrons
    transport cholesterol to peripheral tissues
  13. statins MOA
    inhibits HMG-CoA reductase
  14. desired TG levels are under ___ mg/dL
    150
  15. "bad cholesterol"
    LDL
  16. exogenous cholesterol metabolism
    supplementation of cholesterol from diet
  17. women over __ years have a higher ASCVD risk
    55
  18. men over __ years have a higher ASCVD risk
    45
  19. drug class of colestipol
    bile acid sequestrants
  20. desired total cholesterol levels are under ___ mg/dL
    200